A Study to Assess the Effect of Avacopan at Therapeutic and Supratherapeutic Doses on the QT/QTc Interval in Healthy Participants

Name: A Study to Assess the Effect of Avacopan at Therapeutic and Supratherapeutic Doses on the QT/QTc Interval in Healthy Participants
Published: 2019
License: Public Domain

Amgen · 2019

ClinicalTrials.gov · Datasets · License: Public Domain · 2019

Open Source ↗

complement electrocardiography

electrocardiography, complement 5a receptor (c5ar), anti-neutrophil cytoplasmic antibody-associated vasculitis, complement, vasculitis, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Assess the Effect of Avacopan at Therapeutic and Supratherapeutic Doses on the QT/QTc Interval in Healthy Participants

Related documents